AstraZeneca’s Evusheld slashes risk of symptomatic COVID-19 up to 83%
AstraZeneca's monoclonal antibody combination tixagevimab-cilgavimab (Evusheld) reduced the risk of symptomatic COVID-19 infection by 83% over placebo at a median...
AstraZeneca's monoclonal antibody combination tixagevimab-cilgavimab (Evusheld) reduced the risk of symptomatic COVID-19 infection by 83% over placebo at a median...
Patient contracted Omicron just 20 days after Delta strain of COVID-19A 31-year-old woman from Spain contracted COVID-19 twice within 3...
A third messenger RNA (mRNA) vaccine appears to have proved its worth against COVID-19. And although it is more than...
“Silent Invasion,” an insider’s look at the Trump administration’s pandemic policies, is earnest and exhaustive, our reviewer says.SILENT INVASION: The...
A new study of 23.1 million Scandinavians suggests that the risk of myocarditis after mRNA COVID-19 vaccination is low but...
When someone in the family tests positive for the coronavirus, there are some guidelines to follow.Though I have been writing...
When it first hit the market in December, the COVID-19 antiviral treatment, Paxlovid, was hailed as a game-changer, an effective...
LOS ANGELES (KABC) -- A Princess Cruise ship returned to Los Angeles this week after an unknown number of passengers...
The abrupt end of the federal mask mandate for public transportation and an uptick in coronavirus cases across the country...
After backlash on social media, Delta Air Lines has walked back a comment falsely claiming that the coronavirus, which continues...